Histological changes of the dopaminergic nigrostriatal system in aging

Although the maximum human lifespan has not increased in recent history, average life expectancy has risen dramatically since the beginning of the last century. Lengthening of lifespan has little merit if the quality of life is not preserved. In the elderly, the decline in memory and cognitive abilities is of great concern, as is motor weakening, which increases with age. The dopaminergic system mediates some aspects of manual dexterity, in addition to cognition and emotion, and may be especially vulnerable to aging. Therefore, the aging of this system has both clinical and vocational aspects. This review includes studies quantitating age-related changes of the nigrostriatal system, with emphasis on the use of stereological methods, and provides tables of stereological studies performed in the nigrostriatal system.

[1]  J. Rinne,et al.  Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease , 2002, Neuroscience & Biobehavioral Reviews.

[2]  K. Wieczorowska-Tobis,et al.  Pathophysiology of ageing. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[3]  Introduction to Autonomic Pharmacology , 1965 .

[4]  K. Leenders,et al.  Dopamine D2 Receptors in Normal Human Brain: Effect of Age Measured by Positron Emission Tomography (PET) and [11C]‐Raclopride a , 1993, Annals of the New York Academy of Sciences.

[5]  S. Kish,et al.  Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease , 1992, Journal of neurochemistry.

[6]  J. Seibyl,et al.  Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Links,et al.  In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex Differences a , 1988, Annals of the New York Academy of Sciences.

[8]  K. Suzuki,et al.  Age-related changes in human D1 dopamine receptors measured by positron emission tomography , 2005, Psychopharmacology.

[9]  Patrick R Hof,et al.  Practical approaches to stereology in the setting of aging- and disease-related brain banks , 2000, Journal of Chemical Neuroanatomy.

[10]  J. Holden,et al.  Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.

[11]  J. Holden,et al.  Age‐dependent decline of dopamine D1 receptors in human brain: A PET study , 1998, Synapse.

[12]  A. Carlsson.  Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. , 1987, Gerontology.

[13]  B. Pakkenberg,et al.  Neocortical neuron number in humans: Effect of sex and age , 1997, The Journal of comparative neurology.

[14]  A. Planas,et al.  MPP+ Injection into Rat Substantia Nigra Causes Secondary Glial Activation but Not Cell Death in the Ipsilateral Striatum , 2000, Neurobiology of Disease.

[15]  Päivi Marjamäki,et al.  Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.

[16]  D. Mash,et al.  Immunochemical analysis of dopamine transporter protein in Parkinson's disease , 1997, Annals of neurology.

[17]  B. Shukitt-Hale,et al.  Dopamine neurotoxicity: age-dependent behavioral and histological effects , 2003, Neurobiology of Aging.

[18]  B. Winblad,et al.  Divergent changes in D-1 and D-2 dopamine binding sites in human brain during aging , 1987, Neurobiology of Aging.

[19]  P. Mcgeer,et al.  Aging and extrapyramidal function. , 1977, Archives of neurology.

[20]  P. Yates,et al.  Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.

[21]  G. Vauquelin,et al.  D1 and D2 Dopamine Receptors in Human Substantia Nigra: Localization and the Effect of Aging , 1991, Journal of neurochemistry.

[22]  M. Grégoire,et al.  Anatomic and Biochemical Correlates of the Dopamine Transporter Ligand 11C-PE2I in Normal and Parkinsonian Primates: Comparison with 6-[18F]Fluoro-L-Dopa , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  M. Gallagher,et al.  Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Felberg,et al.  Cell death in experimental intracerebral hemorrhage: The “black hole” model of hemorrhagic damage , 2002, Annals of neurology.

[25]  B. Pakkenberg,et al.  A stereological study of substantia nigra in young and old rhesus monkeys , 1995, Brain Research.

[26]  L. Giovannelli,et al.  Vulnerability to DNA damage in the aging rat substantia nigra: a study with the comet assay , 2003, Brain Research.

[27]  A. Horita,et al.  Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta) , 1987, Neurobiology of Aging.

[28]  J. De Keyser,et al.  Age‐related changes in the human nigrostriatal dopaminergic system , 1990, Annals of neurology.

[29]  M. Reyes,et al.  The aging substantia nigra: quantitative histologic study. , 1994, Panminerva medica.

[30]  D. Charney,et al.  Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT , 1995 .

[31]  J. Rinne,et al.  Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts , 1997, Journal of the Neurological Sciences.

[32]  D. Mash,et al.  Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra , 1999, The Journal of comparative neurology.

[33]  Jens Christian Sørensen,et al.  Memory impaired aged rats: No loss of principal hippocampal and subicular neurons , 1996, Neurobiology of Aging.

[34]  A. Møller.  Mean volume of pigmented neurons in the substantia nigra in Parkinson's disease , 1992, Acta neurologica Scandinavica. Supplementum.

[35]  T. Himi,et al.  Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the aging rat brain. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[36]  H. Braak,et al.  Pigmentoarchitectonic pathology of the isocortex in juvenile neuronal ceroid-lipofuscinosis: Axonal enlargements in layer IIIab and cell loss in layer V , 1979, Acta Neuropathologica.

[37]  C. Kawas,et al.  The CA1 Region of the Human Hippocampus Is a Hot Spot in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[38]  Y. Agid,et al.  Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.

[39]  H. Kimura,et al.  Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrast with loss in Parkinson's disease , 1994, Brain Research.

[40]  G. Šimić,et al.  Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease , 1997, The Journal of comparative neurology.

[41]  T. Kameyama,et al.  Changes in muscarinic cholinergic, PCP, GABAA, D1, and 5-HT2A receptor binding, but not in benzodiazepine receptor binding in the brains of aged rats. , 1994, Life sciences.

[42]  E. Cochran,et al.  Age‐related decreases in Nurr1 immunoreactivity in the human substantia nigra , 2002, The Journal of comparative neurology.

[43]  O. Andreassen,et al.  Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method , 1996, The Journal of comparative neurology.

[44]  B. Volpe,et al.  Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions , 1998, Neuroscience.

[45]  D. Oorschot.  Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: A stereological study using the cavalieri and optical disector methods , 1996, The Journal of comparative neurology.

[46]  K. Blennow,et al.  Brain monoaminergic and neuropeptidergic variations in human aging , 2005, Journal of Neural Transmission.

[47]  N. Volkow,et al.  Dopamine transporters decrease with age. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[48]  H. Nakayama,et al.  Age-related histological changes in the canine substantia nigra. , 2003, The Journal of veterinary medical science.

[49]  G. Gerhardt,et al.  Changes in somatodendritic but not terminal dopamine
regulation in aged rhesus monkeys , 2002, Journal of neurochemistry.

[50]  D. Ingram,et al.  Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice , 1998, Neurobiology of Aging.

[51]  H J Gundersen,et al.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[52]  C. Barton,et al.  Variations in melanin content with age in the human substantia nigra. , 1977, Biochemistry and experimental biology.

[53]  T. Crow,et al.  Striatal dopamine receptors in Alzheimer-type dementia , 1984, Neuroscience Letters.

[54]  U. Muthane,et al.  Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.

[55]  P. Yates,et al.  Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. , 1984, Clinical neuropathology.

[56]  C. Finch,et al.  Dopaminergic Changes in the Basal Ganglia A Generalized Phenomenon of Aging in Mammals a , 1988, Annals of the New York Academy of Sciences.

[57]  K. Jellinger,et al.  Ageing and Dementia , 1998, Journal of Neural Transmission. Supplementa.

[58]  M. Naoi,et al.  Cell death of dopamine neurons in aging and Parkinson’s disease , 1999, Mechanisms of Ageing and Development.

[59]  S. Reeves,et al.  Ageing and the nigrostriatal dopaminergic system , 2002, International journal of geriatric psychiatry.

[60]  L. Becker,et al.  Brain morphology in Duchenne muscular dystrophy: a Golgi study. , 1988, Pediatric neurology.

[61]  B. Winblad,et al.  Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine Levels in human basal ganglia , 2005, Journal of Neural Transmission.

[62]  Laszlo Zaborszky,et al.  The Midbrain Dopaminergic System: Anatomy and Genetic Variation in Dopamine Neuron Number of Inbred Mouse Strains , 2001, Behavior genetics.

[63]  W. Gibb,et al.  Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[64]  B. Volpe,et al.  Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice , 2003, Brain Research.

[65]  K. Unsicker,et al.  Morphological alterations in the amygdala and hippocampus of mice during ageing , 2002, The European journal of neuroscience.

[66]  Y. Lamour,et al.  Age-related changes in dopaminergic and serotonergic indices in the rat forebrain , 1989, Neurobiology of Aging.

[67]  K. Fuxe,et al.  Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury , 2001, Neuroreport.

[68]  Ma,et al.  Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing , 1999, Neuropathology and applied neurobiology.

[69]  B. Katzung.  Basic and Clinical Pharmacology , 1982 .

[70]  J. Rinne.  Muscarinic and dopaminergic receptors in the aging human brain , 1987, Brain Research.

[71]  G. Roth,et al.  The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. , 2000, Antioxidants & redox signaling.

[72]  R. Killiany,et al.  Age-related neuronal loss from the substantia nigra-pars compacta and ventral tegmental area of the rhesus monkey. , 1999, Journal of neuropathology and experimental neurology.

[73]  J. Joseph,et al.  Decreased striatal D2 dopamine receptor mRNA synthesis during aging. , 1993, Brain research. Molecular brain research.

[74]  A. Rajput,et al.  Age, environments, and the number of substantia nigra neurons. , 1990, Advances in neurology.

[75]  J. Marcusson,et al.  Age‐Correlated Loss of Dopaminergic Binding Sites in Human Basal Ganglia , 1982, Journal of neurochemistry.

[76]  S. Leff,et al.  Age‐related decreases in GTP‐cyclohydrolase‐I immunoreactive neurons in the monkey and human substantia nigra , 2000, The Journal of comparative neurology.

[77]  S. Weis,et al.  Cytochrome c oxidase defects of the human substantia nigra in normal aging , 1996, Neurobiology of Aging.

[78]  P. Yates,et al.  The effects of ageing on the pigmented nerve cells of the human locus caeruleus and substantia nigra , 1979, Acta Neuropathologica.

[79]  E. Tolosa,et al.  Neuronal Changes in the Substantia Nigra with Aging: A Golgi Study , 1995, Journal of neuropathology and experimental neurology.

[80]  K. Fuxe,et al.  Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion , 2004, Experimental Brain Research.

[81]  Y. Agid,et al.  Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. , 1997, Histology and histopathology.

[82]  Chin-peng Lee,et al.  Gestational Diabetes mellitus and Neonatal Hyperthyrotropinemia , 2002, Gynecologic and Obstetric Investigation.

[83]  B. Pakkenberg,et al.  Ageing of substantia nigra in humans: 
cell loss may be compensated by hypertrophy , 2002, Neuropathology and applied neurobiology.

[84]  D. Boire,et al.  Stereological evaluation of substantia nigra cell number in normal and hemispherectomized monkeys , 1999, Brain Research.

[85]  H. Gundersen.  Stereology of arbitrary particles * , 1986, Journal of microscopy.

[86]  H. Steinbusch,et al.  Perinatal Asphyxia Induced Neuronal Loss by Apoptosis in the Neonatal Rat Striatum: A Combined TUNEL and Stereological Study , 2002, Experimental Neurology.

[87]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[88]  M. Bannon,et al.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Pl Lantos,et al.  Greenfield's Neuropathology , 1985 .

[90]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[91]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.

[92]  G. Gerhardt,et al.  Aged Fischer 344 rats exhibit altered orolingual motor function: relationships with nigrostriatal neurochemical measures , 2003, Neurobiology of Aging.

[93]  B. Volpe,et al.  Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury , 1998, Brain Research.

[94]  Oleg Shupliakov,et al.  Evidence for neurogenesis in the adult mammalian substantia nigra , 2003, Proceedings of the National Academy of Sciences of the United States of America.